NRX Pharmaceuticals Inc expected to post a loss of 10  cents a share - Earnings Preview

NRX Pharmaceuticals

12/08/2022 13:59

* NRX Pharmaceuticals Inc  NRXP.OQ   NRXP.O  is expected
to report
results on August 15 (estimated).
    * ​Refinitiv's mean analyst estimate for NRX Pharmaceuticals
Inc
is for a loss of 10 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for NRX
Pharmaceuticals Inc is $2​, above​ its last closing price
of $0.81. ​​​

This summary was machine generated August 12 at 12:59 GMT.  All
figures in US dollars  unless otherwise stated